Artivion (AORT) vs Alphatec (ATEC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Artivion (AORT) has outperformed Alphatec (ATEC) over the past year, losing 59.8% versus a loss of 67.1%. Over five years, AORT leads with a -0.8% price change compared with -36.8% for ATEC. Alphatec is the larger company by market cap ($1.02 billion vs $886.0 million), about 1.2 times the size.
On valuation, Alphatec trades at a lower forward P/E (12.0x vs 34.9x for Artivion). Artivion converts more of its revenue into profit, with a net margin of 2.2% versus -18.8%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AORT | ATEC |
|---|---|---|
| Share price | $18.16 | $6.68 |
| Market cap | $886.02M | $1.02B |
| 1-day change | -2.00% | -3.19% |
| YTD return | -60.18% | -68.25% |
| 1-year return | -59.76% | -67.11% |
| 5-year return | -0.82% | -36.80% |
| Forward P/E | 34.92 | 11.97 |
| EPS (TTM) | $-0.36 | $-0.57 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $441.33M | $764.15M |
| Revenue growth (YoY) | +13.59% | +24.95% |
| Net income (latest FY) | $9.77M | $-143.36M |
| Gross margin | 64.40% | 69.60% |
| Operating margin | 7.65% | -10.75% |
| Net margin | 2.21% | -18.76% |
| 52-week high | $48.25 | $23.29 |
| 52-week low | $18.12 | $6.63 |
| Distance from 52-week high | -62.36% | -71.32% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +111.84% | +93.56% |
| Average volume | 671.97K | 3.38M |
| Shares outstanding | 48.79M | 153.33M |
| Employees | 1,800 | 913 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Artivion is more profitable, keeping 2.2 cents of every revenue dollar as net income versus -18.8 cents for Alphatec.
- Alphatec grew revenue faster in its latest fiscal year (+24.95% vs +13.59%).
About Artivion
AORT stock →Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide.
Health Care · Medical/Dental Instruments · 1,800 employees
About Alphatec
ATEC stock →Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts.
Health Care · Medical/Dental Instruments · 913 employees
AORT vs ATEC FAQ
Which is bigger, Artivion or Alphatec?
Alphatec (ATEC) is larger, with a market capitalization of $1.02B compared with $886.02M for Artivion (AORT).
Which stock has performed better over the past year, AORT or ATEC?
AORT returned -59.76% over the past 12 months, compared with -67.11% for ATEC (price return, excluding dividends). Past performance does not predict future results.
Are Artivion and Alphatec in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.